Potentiation of quinazoline antifolate (CB3717) toxicity by dipyridamole in human lung carcinoma, A549, cells

Biochemical Pharmacology

Volumn 37, Issue 11, 1988, Pages 2113-2120

  Curtin, Nicola J ^a   Harris, Adrian L ^a  

^a Cancer Research Unit University of Newcastle upon Tyne Royal Victoria Infirmary Newcastle upon Tyne NE1LP UK ^*

Author keywords

[No Author keywords available]

Indexed keywords

10 PROPARGYL 5,8 DIDEAZAFOLIC ACID; DEOXYURIDINE; DIPYRIDAMOLE; RADIOISOTOPE; THYMIDINE;

CELL CULTURE; HUMAN CELL; LUNG CANCER;

CARCINOMA; CELL SURVIVAL; DIPYRIDAMOLE; DNA; DRUG SYNERGISM; FOLIC ACID; FOLIC ACID ANTAGONISTS; HUMAN; LUNG NEOPLASMS; QUINAZOLINES; SUPPORT, NON-U.S. GOV'T; THYMIDINE; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED;

EID: 0023927390     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(88)90568-0     Document Type: Article

References (43)

1. A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice
2. Biochemical effects of quinazoline inhibitor of thymidylate synthetase CB3717 on human lymphoblastoid cells
3. Modulation of antimetabolite effects: Effects of thymidine on the efficacy of quinazoline-based thymidylate synthetase inhibitor CB3717
4. Quantitative HPLC of nucleosides and bases in human plasma
5. Significance of variation of serum thymidine concentrations for the marrow toxicity of methotrexate
6. Enzymology of pyrimidine and carbohydrate metabolism in human colon cancer
7. Biochemical strategy of cancer cells and design of chemotherapy.G.H.A. Clowes Memorial Lecture
8. In vivo studies with an inhibitor of nucleoside transport, nitrobenzylthioinosine-5-monophosphate
9. The deoxyribonucleoside transport systems of cultured Novikoff rat hepatoma cells
10. Potentiation of methotrexate toxicity by dipyridamole
11. Dipyridamole augments the cytotoxicity of methotrexate against human colon cancer cells
12. Potentiation of methotrexate toxicity in human lymphoblastoid cells by nitrobenzylthioinosine and dipyridamole
13. Effects of acivicin and dipyridamole on hepatoma 3924A cells
14. Enhancement of sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole
15. Mechanism of synergy between PALA and dipyridamole in human ovarian carcinoma cell line
16. Modulation of activity of PALA by dipyridamole
17. Salvage capacity of hepatoma 3924A and the action of dipyridamole
18. In vitro cultivation of human tumours: establishment of cell lines derived from a series of solid tumours
19. A continuous tumour cell-line from a human lung carcinoma with properties of type II alveolar epithelial cells
20. Thymidine concentrations in serum and urine of different animal species and man
21. Thin layer separation methods for nucleic acid derivatives
22. 10-propargyl-5,8-dideazafolic acid (CB3717)
23. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate
24. Inhibition of the growth of human hepatocellular carcinoma cells in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase CB3717
25. Pharmacokinetics of oral dipyridamole (Persantine) and its effects on platelet adenosine uptake in man
26. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole
27. Modulation of fluorouracil metabolism and cytotoxicity of nitrothiobenzylinosine
28. Sequential dipyridamole retards Ara C efflux and results in synergistic cytotoxicity
29. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxy-coformycin combinations in vitro
30. Studies on the replication of DNA by DNA polymerases
31. Distinctive properties of mammalian DNA polymerase
32. Uracil incorporation into nascent DNA of thymine requiring mutant of Bacillus subtilis 168
33. Uracil incorporation: a source of pulse-labelled DNA fragments in the replication of the Escherichia coli chromosome
34. Deoxyuridine residues in DNA of Bacillus subtilis strains with defective N-glycosidase activity for uracil containing DNA
35. Methotrexateinduced misincorporation of uracil in DNA
36. Antifolate induced misincorporation of deoxyuridine monophosphate into DNA: Inhibition of high molecular weight DNA synthesis in human lymphoblastoid cells
37. DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate
38. The regulation of thymidylate biosynthesis in Novikoff hepatoma cells and the effects of ame-thopterin, 5-fluorodeoxyuridine and 3-deazauridine
39. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels
40. Accumulation of DNA strand breaks during thymineless death in thymidylate synthase negative mutants of mouse FM3A cells
41. Is uracil misincorporation into DNA of mammalian cells a consequence of methotrexate treatment
42. Dipyridamole kinetics
43. Inhibition of human platelet aggregation by dipyridamole and two related compounds and its modification by acid glycoproteins of human plasma